Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Gains from Investment Securities (2016 - 2022)

Historic Gains from Investment Securities for Bio Key International (BKYI) over the last 12 years, with Q3 2022 value amounting to $140000.0.

  • Bio Key International's Gains from Investment Securities changed N/A to $140000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $55989.0, marking a year-over-year decrease of 4226.99%. This contributed to the annual value of $79521.0 for FY2024, which is N/A changed from last year.
  • Per Bio Key International's latest filing, its Gains from Investment Securities stood at $140000.0 for Q3 2022.
  • Bio Key International's Gains from Investment Securities' 5-year high stood at $351918.0 during Q4 2018, with a 5-year trough of $40995.0 in Q1 2020.
  • For the 3-year period, Bio Key International's Gains from Investment Securities averaged around $147225.5, with its median value being $97994.5 (2020).
  • Over the last 5 years, Bio Key International's Gains from Investment Securities had its largest YoY gain of 7148.54% in 2018, and its largest YoY loss of 7148.54% in 2018.
  • Quarter analysis of 3 years shows Bio Key International's Gains from Investment Securities stood at $351918.0 in 2018, then tumbled by 84.09% to $55989.0 in 2020, then skyrocketed by 150.05% to $140000.0 in 2022.
  • Its last three reported values are $140000.0 in Q3 2022, $55989.0 for Q2 2020, and $40995.0 during Q1 2020.